SEC Form 4 · accession 0001209191-15-061522
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
W Robert Dahl Jr.
Director
Period of report
Jul 16, 2015
Accepted (ET)
Jul 17, 2015 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Jul 16, 2015 | M | 9,568 | $22.97 | A | 52,808 | D | |
| Common Stock, $0.01 par value | Jul 16, 2015 | F | 6,050 | $36.33 | D | 46,758 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $22.97 | Jul 16, 2015 | M | 9,568 | D | — | Jul 23, 2015 | Common Stock, $.01 par value | 9,568 | 0 | D |
Explanation of responses
- F1The options vested in the following amounts on the following dates: 3,189 on 07/24/2009, 3,189 options on 07/24/2010 and 3190 options on 07/24/2011.